Home/Pipeline/Promarker™Eso

Promarker™Eso

Esophageal adenocarcinoma

CommercialActive

Key Facts

Indication

Esophageal adenocarcinoma

Phase

Commercial

Status

Active

Company

Proteomics International

About Proteomics International

Australian proteomics company delivering early‑detection blood tests for kidney, cancer and gynecologic diseases.

View full company profile

Therapeutic Areas

Nephrology Oncology Gynecology